Work

POSTER: AML-1310 Subgroup Analysis by Fitness Criteria of Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With First-Line Tagraxofusp

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)00639-1

Authors: Naveen Pemmaraju, Marco Herling, Kendra L. Sweet, Anthony S. Stein, Sumithira Vasu, Todd L. Rosenblat, David A. Rizzieri, Cristina Papayannidis, Eunice S.Wang, Marina Konopleva, Michael Zuurman, Alessandra Tosolini, Muzaffar Qazilbash, Andrew A. Lane

Institutions: The University of Texas MD Anderson Cancer Center, University Hospital Leipzig, Moffitt Cancer Center, City Of Hope National Medical Center, City of Hope, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Herbert Irving Comprehensive Cancer Center, Novant Health, Istituto di Ematologia di Bologna, Roswell Park Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Histiocytic Disorders and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413775289

FWCI:

Cites:

Cited by:

Related to: 10